Loss-of-function approaches showed that linc-ROR depletion suppressed cell proliferation, cell motility, and chemoresistance in vitro and attenuated tumor growth in vivo, in line with recent evidences in other solid tumors such as breast [41] and pancreatic cancer [42]. The gene discussed is LINC-ROR; the disease is neoplasm.